338 related articles for article (PubMed ID: 12435665)
1. In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model.
Jacqueline C; Batard E; Perez L; Boutoille D; Hamel A; Caillon J; Kergueris MF; Potel G; Bugnon D
Antimicrob Agents Chemother; 2002 Dec; 46(12):3706-11. PubMed ID: 12435665
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Dailey CF; Dileto-Fang CL; Buchanan LV; Oramas-Shirey MP; Batts DH; Ford CW; Gibson JK
Antimicrob Agents Chemother; 2001 Aug; 45(8):2304-8. PubMed ID: 11451689
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Chiang FY; Climo M
Antimicrob Agents Chemother; 2003 Sep; 47(9):3002-4. PubMed ID: 12937013
[TBL] [Abstract][Full Text] [Related]
5. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus.
Jacqueline C; Navas D; Batard E; Miegeville AF; Le Mabecque V; Kergueris MF; Bugnon D; Potel G; Caillon J
Antimicrob Agents Chemother; 2005 Jan; 49(1):45-51. PubMed ID: 15616274
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of linezolid in a staphylococcal endocarditis rabbit model.
Oramas-Shirey MP; Buchanan LV; Dileto-Fang CL; Dailey CF; Ford CW; Batts DH; Gibson JK
J Antimicrob Chemother; 2001 Mar; 47(3):349-52. PubMed ID: 11222569
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection.
Yanagihara K; Kaneko Y; Sawai T; Miyazaki Y; Tsukamoto K; Hirakata Y; Tomono K; Kadota J; Tashiro T; Murata I; Kohno S
Antimicrob Agents Chemother; 2002 Oct; 46(10):3288-91. PubMed ID: 12234863
[TBL] [Abstract][Full Text] [Related]
9. In vivo activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457.
Hilliard JJ; Fernandez J; Melton J; Macielag MJ; Goldschmidt R; Bush K; Abbanat D
Antimicrob Agents Chemother; 2009 May; 53(5):2028-33. PubMed ID: 19273686
[TBL] [Abstract][Full Text] [Related]
10. Is linezolid superior to vancomycin for complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus?
Kalil AC; Puumala S; Stoner J
Antimicrob Agents Chemother; 2006 May; 50(5):1910; author reply 1910-1. PubMed ID: 16641477
[No Abstract] [Full Text] [Related]
11. In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus.
Jacqueline C; Caillon J; Grossi O; Le Mabecque V; Miegeville AF; Bugnon D; Batard E; Potel G
Antimicrob Agents Chemother; 2006 Jul; 50(7):2547-9. PubMed ID: 16801442
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides.
Ribes S; Pachón-Ibáñez ME; Domínguez MA; Fernández R; Tubau F; Ariza J; Gudiol F; Cabellos C
Eur J Clin Microbiol Infect Dis; 2010 Nov; 29(11):1361-7. PubMed ID: 20680368
[TBL] [Abstract][Full Text] [Related]
13. Time-dependent antibacterial effects of linezolid in experimental rabbit endocarditis.
Buchanan LV; Dailey CF; LeMay RJ; Zielinski RJ; Kuo MS; Gibson JK
J Antimicrob Chemother; 2002 Sep; 50(3):440-2. PubMed ID: 12205079
[No Abstract] [Full Text] [Related]
14. Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
Corne P; Marchandin H; Macia JC; Jonquet O
Scand J Infect Dis; 2005; 37(11-12):946-9. PubMed ID: 16308242
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
Madrigal AG; Basuino L; Chambers HF
Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vivo efficacies of epithelial lining fluid exposures of tedizolid, linezolid, and vancomycin for methicillin-resistant Staphylococcus aureus in a mouse pneumonia model.
Tessier PR; Keel RA; Hagihara M; Crandon JL; Nicolau DP
Antimicrob Agents Chemother; 2012 May; 56(5):2342-6. PubMed ID: 22354302
[TBL] [Abstract][Full Text] [Related]
17. Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus.
Tattevin P; Basuino L; Bauer D; Diep BA; Chambers HF
Antimicrob Agents Chemother; 2010 Feb; 54(2):610-3. PubMed ID: 19917746
[TBL] [Abstract][Full Text] [Related]
18. Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
Marco F; de la Mària CG; Armero Y; Amat E; Soy D; Moreno A; del Río A; Almela M; Mestres CA; Gatell JM; Jiménez de Anta MT; Miró JM;
Antimicrob Agents Chemother; 2008 Jul; 52(7):2538-43. PubMed ID: 18426900
[TBL] [Abstract][Full Text] [Related]
19. Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid.
Ruiz ME; Guerrero IC; Tuazon CU
Clin Infect Dis; 2002 Oct; 35(8):1018-20. PubMed ID: 12355391
[TBL] [Abstract][Full Text] [Related]
20. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
Stevens DL; Herr D; Lampiris H; Hunt JL; Batts DH; Hafkin B
Clin Infect Dis; 2002 Jun; 34(11):1481-90. PubMed ID: 12015695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
